The technology of puberty suppression
As a treatment for gender dysphoria in adolescents, gonadotropin-releasing hormone agonist (GnRHa) is now commonly prescribed to suppress puberty from the age of 12 or younger. Puberty suppression is also central to the transgender imaginary as an endocrinological intervention that promises a more c...
| Yazar: | |
|---|---|
| Diğer Yazarlar: | |
| Materyal Türü: | Book section |
| Dil: | English |
| Baskı/Yayın Bilgisi: |
Routledge
2023
|